Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Seminars in Hematology|July 15, 2005
Alternative treatments for myelodysplastic syndromesMikkael Sekeres, Alan ListClinical Advances in Hematology & Oncology : H&O|December 2, 2006
Managing patients with low-risk MDSMikkael Sekeres, Denise Cosgrove, Angela FalcoClinical Advances in Hematology & Oncology : H&O|November 26, 2009
Evolving strategies in the treatment of MDS and AMLRichard Stone, Mikkael Sekeres, Guillermo Garcia-ManeroAnesthesia and Analgesia|May 29, 2002
Mortality and adverse events after protamine administration in patients undergoing cardiopulmonary bypassStephen E Kimmel, Mikkael Sekeres, Jesse A Berlin, et al.Clinical Advances in Hematology & Oncology : H&O|April 23, 2009
Recent advances in low- and intermediate-1-risk myelodysplastic syndrome: developing a consensus for optimal therapyRichard Stone, Mikkael Sekeres, Guillermo Garcia-Manero, et al.Cleveland Clinic Journal of Medicine|March 5, 2020
Severe megaloblastic anemia: Vitamin deficiency and other causesDaniel S Socha, Sherwin I DeSouza, Aron Flagg, et al.International Journal of Hematology|February 19, 2015
Genetic and molecular characterization of myelodysplastic syndromes and related myeloid neoplasmsBhumika Patel, Cassandra Hirsch, Michael Clemente, et al.American Journal of Hematology|August 30, 2008
Timed sequential induction chemotherapy and risk-adapted postremission therapy for acute myelogenous leukemiaMatt Kalaycio, Anjali Advani, Brad Pohlman, et al.Leukemia & Lymphoma|May 13, 2006
The role of post-remission chemotherapy for older patients with acute myelogenous leukemiaRony M Abou-Jawde, Ronald Sobecks, Brad Pohlman, et al.Clinical Lymphoma, Myeloma & Leukemia|August 18, 2018
Ruxolitinib Rechallenge Can Improve Constitutional Symptoms and Splenomegaly in Patients With Myelofibrosis: A Case SeriesAaron Gerds, Derrick Su, Anastasia Martynova, et al.Pageof 3